Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization

Virology

Volumn 268, Issue 2, 2000, Pages 493-503

  Fortin, Jean François ^a   Cantin, Réjean ^a   Bergeron, Michel G ^a   Tremblay, Michel J ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ADULT; ANIMAL CELL; ARTICLE; CASE REPORT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SERUM; STRAIN DIFFERENCE; TARGET CELL; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION; VIRUS RESISTANCE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034654024     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0190     Document Type: Article

References (64)

1. Adachi A., Gendelman H. E., Koenig S., Folks T., Willey R., Rabson A., Martin M. A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman transfected cells with an infectious molecular clone. J. Virol. 59:1986;284-291.
2. Aguilar-Cordova E., Chinen J., Donehower L., Lewis D. E., Belmont J. W. A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res. Hum. Retroviruses. 10:1994;295-301.
3. Alkhatib G., Combadiere C., Broder C. C., Feng Y., Kennedy P. E., Murphy P. M., Berger E. A. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1996;1955-1958.
4. Arthos J., Deen K. C., Chaikin M., Fornwald J. A., Sathe g., Sattentau Q. J., Clapham P. R., Weiss R. A., McDougal S. J., Pietropaolo C., Axel R., Truneh A., Maddon P. J., Sweet R. W. Identification of the residues in human CD4 critical for the binding of HIV. Cell. 57:1989;469-481.
5. Bastiani L., Laal S., Kim M., Zolla-Pazner S. Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions. J. Virol. 71:1997;3444-3450.
6. Benkirane M., Blanc-Zouaoui D., Hirn M., Devaux C. Involvement of human leukocyte antigen class I molecules in human immunodeficiency virus infection of CD4-positive cells. J. Virol. 68:1994;6332-6339.
7. Berger E. A., Doms R. W., Fenyö E.-M., Korber B. T. M., Littman D. R., Moore J. P., Sattentau Q. J., Schuitemaker H., Sodroski J., Weiss R. A. A new classification for HIV-1. Nature. 391:1998;240.
8. Berman P. W., Nakamura G. R. Adhesion mediated by intercellular adhesion molecule 1 attenuates the potency of antibodies that block HIV-1 gp160-dependent syncytium formation. AIDS Res. Hum. Retroviruses. 10:1994;585-593.
9. Binley J., Moore J. P. The viral mousetrap. Nature. 387:1997;346-348.
10. Cantin R., Fortin J.-F., Lamontagne G., Tremblay M. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J. Virol. 71:1997;1922-1930.
11. Cantin R., Fortin J.-F., Tremblay M. The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. Virology. 218:1996;372-381.
12. Castilletti C., Capobianchi M. R., Fais S., Abbate I., Ficociello B., Ameglio F., Cordiali Fei P., Santini S. M., Dianzani F. HIV type 1 grown on interferon γ-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells. AIDS Res. Hum. Retroviruses. 11:1995;547-553.
13. Choe H., Farzan M., Sun Y., Sullivan N., Barrett R., Ponath P. D., Wu L., Mackay C. R., LaRosa G., Newman W., Gerard N., Gerard G., Sodroski J. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1996;1135-1148.
14. Clapham P. R., Weber J. N., Whitby D., McIntosh K., Dalgeish A. G., Maddon P. J., Deen K. C., Sweet R. W., Weiss R. A. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature. 227:1989;368-370.
15. Cornelissen M., Mulder-Kampinga G., Veenstra J., Zorgdrager F., Kuiken C., Hartman S., Dekker J., van der Hoek L., Sol C., Coutinho R. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J. Virol. 69:1995;1810-1818.
16. Dalgleish A. G., Beverly P. C. L., Clapham P. R., Crawford D. H., Greaves M. F., Weiss R. A. The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 312:1984;763-767.
17. Deen K. C., McDougal S. J., Inacker R., Folena-Wasserman G., Arthos J., Rosenberg j., Jay Maddon P., Axel R., Sweet R. W. A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature. 331:1988;82-84.
18. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R. E., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
19. Doranz B. J., Rucker J., Yanjie Y., Smyth R. J., Samson M., Peiper S. C., Parmentier M., Collman R. G., Doms R. W. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR2b as fusion cofactors. Cell. 85:1996;1149-1158.
20. Dragic T., Litwin V., Allaway G. P., Martin S. R., Huang Y., Nagashima K. A., Cayanan C., Maddon P. J., Koup R. A., Moore J. P., Paxton W. A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
21. Dustin M. L., Springer T. A. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature. 341:1989;619-624.
22. Fais S., Capobianchi M. R., Abbate I., Castilletti C., Gentile M., Cordiali Fei P., Ameglio F., Dianzani F. Unidirectional budding of HIV-1 at the site of cell-to-cell contact is associated with copolarization of intercellular adhesion molecules (ICAM-1) and HIV-1 viral matrix protein. AIDS. 9:1995;329-335.
23. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:1996;872-877.
24. Fortin J.-F., Cantin R., Lamontagne G., Tremblay M. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 71:1997;3588-3596.
25. Fortin J.-F., Cantin R., Tremblay M. J. T cells expressing activated LFA-1 are more susceptible to infection with HIV-1 particles bearing host-encoded ICAM-1. J. Virol. 72:1998;2105-2112.
26. Frank I., Stoiber H., Godar S., Stokinger H., Steindl F., Katinger H. W. D., Dierich M. P. Acquisition of host cell-surface-derived molecules by HIV-1. AIDS. 10:1996;1611-1620.
27. Gomez M. B., Hildreth J. E. K. Antibody to adhesion molecule LFA-1 enhances plasma neutralization of human immunodeficiency virus type 1. J. Virol. 69:1995;4628-4632.
28. Henderson L. E., Sowder R., Copeland T. D., Oroszlan S., Arthur L. O., Robey W. G., Fischinger P. J. Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J. Virol. 61:1987;629-632.
29. Hioe C. E., Bastiani L., Hildreth J. E. K., Zolla-Pazner S. Role of cellular adhesion molecules in HIV type 1 infection and their impact on virus neutralization. AIDS Res. Hum. Retroviruses. 14:1998;S247-S254.
30. Hoxie J., Fitzharris T. P., Yougbar P. R., Matthews D. M., Rackowski J. L., Radka S. F. Nonrandom association of cellular antigens with HTLV-III virions. Hum. Immunol. 18:1987;39-52.
31. Hunter E. Macromolecular interactions in the assembly of HIV and other retroviruses. Semin. Virol. 5:1994;71-83.
32. Karlsson G. B., Gao F., Robinson J., Hahn B., Sodroski J. Increased spike density and stability are not required for the neutralization resistance of primary human immunodeficiency viruses. J. Virol. 70:1996;6136-6142.
33. Keizer G. D., Visser W., Vliem M., Figdor C. G. A monoclonal antibody (NKI-L16) directed against a unique epitope on the α-chain of human leukocyte function-associated antigen 1 induces homotypic cell-cell interactions. J. Immunol. 140:1988;1393-1400.
34. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J. C., Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 312:1984;767-768.
35. LaCasse R. A., Follis K. E., Moudgil T., Trahey M., Binley J. M., Planelles V., Zolla-Pazner S., Nunberg J. H. Coreceptor utilization by human immunodeficiency virus type 1 is not a primary determinant of neutralization sensitivity. J. Virol. 72:1998;2491-2495.
36. Lapham C. K., Ouyang J., Chandrasekhar B., Nguyen N. Y., Dimitrov D. S., Golding H. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science. 274:1996;602-605.
37. Lee Guo M. M., Hildreth J. E. K. HIV acquire functional adhesion receptors from host cells. AIDS Res. Hum. Retroviruses. 11:1995;1007-1013.
38. + T-cell clone (PM1): Failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J. Virol. 69:1995;3712-3720.
39. Marlin S. D., Springer T. A. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell. 51:1987;813-819.
40. Matsushita S., Robert-Guroff M., Rusche J., Koito A., Hattori T., Hoshino H., Javaherian K., Takatsuki K., Putney S. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J. Virol. 62:1988;2107-2114.
41. Matthews T. J. Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development. AIDS Res. Hum. Retroviruses. 10:1994;631-632.
42. Means R. E., Greenough T., Desrosiers R. C. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus. J. Virol. 71:1997;7895-7902.
43. Montefiori D. C., Collman R. G., Fouts T. R., Zhou J. Y., Bilska M., Hoxie J. A., Moore J. P., Bolognesi D. P. Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage. J. Virol. 72:1998;1886-1893.
44. Moore J. P., Cao Y., Qing L., Sattentau Q. J., Pyati J., Koduri R., Robinson J., Barbas C. F. III, Burton D. R., Ho D. D. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69:1995;101-109.
45. Moore J. P., McKeating J. A., Huang Y., Ahkenazi A., Ho D. H. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differs in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J. Virol. 66:1992;235-243.
46. Pantaleo G., Graziosi C., Fauci A. S. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328:1993a;327-335.
47. Pantaleo G., Graziosi C., Fauci A. S. The role of lymphoid organs in the immunopathogenesis of HIV infection. AIDS. 7:1993b;s19-s23.
48. Paquette J.-S., Fortin J.-F., Blanchard L., Tremblay M. J. The level of expression of ICAM-1 on the surface of HIV-1-producer cells influences both the level of incorporation and the virus infectivity. J. Virol. 72:1998;9329-9336.
49. Parrot D. M., Wilkinson P. C. Lymphocyte locomotion and migration. Prog. Allergy. 28:1981;193-284.
50. Pear W. S., Nolan G. P., Scott M. L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:1993;8932-8936.
51. Posner M. R., Cavacini C. A., Emes C. L., Power J., Bym R. Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120. J. Acquir. Immune Defic. Syndr. 6:1993;7-14.
52. Rizzuto C. D., Sodroski J. G. Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization. J. Virol. 71:1997;4847-4851.
53. Rossio J. L., Bess J., Henderson L. E., Cresswell P., Arthur L. O. HLA class II on HIV particles is functional in superantigen presentation to human T cells: Implications for HIV pathogenesis. AIDS Res. Hum. Retroviruses. 11:1995;1433-1439.
54. Rothlein R., Dustin M. L., Marlin S. D., Springer T. A. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol. 137:1986;1270-1274.
55. Saifuddin M., Parker C. J., Peeples M. E., Gorny M. K., Zolla-Pazner S., Ghassemi M., Rooney I. A., Atkinson J. P., Spear G. T. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-l. J. Exp. Med. 182:1995;501-509.
56. Sawyer L. S. W., Terri Wrin M., Crawford-Mita L., Potts B., Wu Y., Weber P. A., Alfonso R. D., Hanson C. V. Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J. Virol. 68:1994;1342-1349.
57. Staunton D. E., Marlin S. D., Stratowa C., Dustin M. L., Springer T. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin families. Cell. 52:1988;925-933.
58. Thali M., Moore J. P., Furman C., Charles M., Ho D. D., Robinson J., Sodroski J. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:1993;3978-3988.
59. Tremblay M. J., Fortin J.-F., Cantin R. The acquisition of host-encoded proteins by nascent HIV-1. Immunol. Today. 19:1998;346-351.
60. Trkola A., Dragic T., Arthos J., Binley J. M., Olson W. C., Allaway G. P., Cheng-Mayer C., Robinson J., Maddon P. J., Moore J. P. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR5. Nature. 384:1996;184-187.
61. Trkola A., Ketas T., KewalRamani V. N., Endorf F., Binley J. M., Katinger H., Robinson J., Littman D. R., Moore J. P. Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage. J. Virol. 72:1998;1876-1885.
62. Ugolini S., Mondor I., Parren P. W. H. I., Burton D. R., Tilley S. A., Klasse P. J., Sattentau Q. J. Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization. J. Exp. Med. 186:1997;1287-1298.
63. Veenstra J., Schuurman R., Cornelissen M., van't Wout A. B., Boucher C. A., Schuitemaker H., Goudsmit J., Coutinho R. A. Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: Characteristics and natural history of the virus. Clin. Infect. Dis. 21:1995;556-560.
64. Weissenhorn W., Dessen A., Harrison S. C., Skehel J. J., Wiley D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature. 387:1997;426-430.